Results 101 to 110 of about 287,756 (345)

Update on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart

open access: yesEuropean Journal of Heart Failure, EarlyView.
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...
Alessandra Ghigo   +22 more
wiley   +1 more source

Sistema epidemiológico de regisro de tumores de hipófisis en el Centro Médico Docente La Trinidad. Período 2017-2020

open access: yesRevista Científica CMDLT, 2022
Los tumores de hipófisis representan la forma más frecuente de tumor intracraneal en 14.7% . La proliferación excesiva y descontrolada son de un origen monoclonal, predominio benigno y crecimiento lento, pero pueden tener significativa morbilidad y ...
José Javier Orozco Barcos   +3 more
doaj   +2 more sources

Manejo actual del adenoma de la ampolla de Vater

open access: yesRevista Colombiana de Cirugía, 2016
A lo largo de la historia, el manejo de los tumores periampulares, malignos o benignos, ha sido la cirugía radical. Sin embargo, la gran complejidad de estos procedimientos, sus complicaciones y su alto índice de mortalidad hicieron impulsar el ...
Jaime Solano   +3 more
doaj  

Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

open access: yesEndocrine reviews, 2013
Pituitary adenomas are one of the most frequent intracranial tumors and occur with a prevalence of approximately 1:1000 in the developed world. Pituitary adenomas have a serious disease burden, and their management involves neurosurgery, biological ...
A. Beckers   +3 more
semanticscholar   +1 more source

Electrochemical Biosensors for Cancer Biomarker Detection: Basic Concept, Design Strategy and Cutting‐Edge Development

open access: yesElectrochemical Science Advances, EarlyView.
ABSTRACT Cancer is a result of uncontrolled cell growth with the potential to damage or spread to another part of the body. It is the deadliest disease in the world; therefore, rapid and sensitive detection is essential to fight it. In the past few decades, many diagnosis tools have been developed to detect cancer and monitor therapy progress.
Md Mobarok Karim, Tahera Lasker
wiley   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

open access: yesEnvironmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons   +17 more
wiley   +1 more source

A Case of Bronchial Adenoma with Liver Metastasis [PDF]

open access: bronze, 1956
Priscilla Kincaid‐Smith, J.-J. Brossy
openalex   +1 more source

Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma

open access: yesClinical Cancer Research, 2014
Purpose: Detecting microRNA (miRNA) in stool is a novel approach for colorectal cancer (CRC) screening. This study aimed to identify stool-based miRNA as noninvasive biomarkers for detection of CRC and adenoma.
C. Wu   +10 more
semanticscholar   +1 more source

Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials

open access: yesExploration, EarlyView.
Intra‐tumoral microbiota, which is a potential component of the tumor microenvironment, has been emerging as a key participant and driving factor in cancer. This article reviews the latest progress in this field, including the microbial community within tumors and its pro‐cancer mechanisms, as well as the anti‐tumor strategies targeting intra‐tumoral ...
Yanan Niu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy